Study summary · research use only
Mangiferin: A natural neuroprotective polyphenol with anti-inflammatory and anti-oxidant properties for depression
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review discusses mangiferin (MGF), a natural polyphenol from the traditional Chinese herb Anemarrhena asphodeloides Bge., and its potential relevance to depression based on preclinical animal-model studies. MGF is described as having a C-glycosyl and phenolic structure conferring antioxidant, anti-inflammatory, and anti-mitochondrial dysfunction properties. In preclinical depression and neurodegenerative disease models, MGF was reported to reduce amyloid-beta deposition, ameliorate cholinergic dysfunction, and increase neurotrophic factors. The review describes MGF as acting through anti-inflammatory mechanisms (inhibiting NLRP3 inflammasome activation, MAPK phosphorylation and downstream NF-κB signaling, and indoleamine 2,3-dioxygenase activity) and antioxidant mechanisms (increasing antioxidant enzymes, inhibiting lipid peroxidation), with modulation of neurotransmission noted as needing further exploration.
Abstract
Depression is a severe global health problem accompanied by persistent low mood that harms the physical and mental health of people and places a substantial economic burden on society. Mangiferin (MGF), a natural polyphenol in the traditional Chinese herb Anemarrhena asphodeloides Bge., can improve neuronal damage, memory, and cognitive deficits, implicating the therapeutic potential of MGF for depression. MGF has a unique C-glycosyl and phenolic structure that endows it with multiple biological properties, e.g., anti-oxidant, anti-inflammatory, and anti-mitochondrial dysfunction. However, the pharmacological role of MGF in depression remains unclear. Therefore, this review describes the neuroprotective effects and the antidepressant mechanisms of MGF in preclinical depression studies. MGF ameliorates cognitive deficits in depression and neurodegenerative diseases animal models by reducing amyloid-beta deposition, ameliorating cholinergic dysfunction, and increasing neurotrophic factors. Also, MGF regulates molecular mechanisms in depressed animals mainly through anti-inflammation (by inhibiting NLRP3 inflammasome activation, mitogen-activated protein kinase phosphorylation and its downstream nuclear factor-кB signaling pathway, and indoleamine 2,3-dioxygenase activity), anti-oxidant (by increasing levels of anti-oxidant enzymes and inhibiting lipid peroxidation). Notably, the potential mechanisms of MGF in treating depression by modulating neurotransmission (e.g., glutamate, dopamine, norepinephrine, and serotonin) need to be further explored. It is hoped to explore further the potential molecular mechanisms of MGF's biological activity in depression and provide directions for further clinical applications.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.